electroCore (FRA:43E0) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:43E0 electroCore Inc FRA:43E0
57 GF Score
Price €8.80
GF Value €6.94
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is electroCore Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:43E0
57GF Score
electroCore Inc FRA:43E0
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is electroCore (FRA:43E0) Overvalued in 2026?

Based on GuruFocus' analysis, electroCore stock appears to be overvalued. The current stock price of €8.80 is trading 26.8% above its estimated GF Value™ of €6.94. GuruFocus considers electroCore to be Modestly Overvalued.

Key valuation signals for FRA:43E0:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €6.94 vs. price of €8.80 (26.8% above fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the FRA:43E0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

electroCore Business Description

Other Exchanges ECOR:USA
Address 200 Forge Way, Suite 205, Rockaway, NJ, USA, 07866
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
57GF Score

Get the complete analysis for FRA:43E0

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.80
Price
€6.94
GF Value